Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PROVAL #3

ACETAMINOPHEN; CODEINE PHOSPHATE

Standard Dose
325MG;30MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PROVAL #3 is listed in Drugs@FDA under application 085685 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength CAPSULE;ORAL - 325MG;30MG Sponsor SOLVAY Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview PROVAL #3 is listed in Drugs@FDA under application 085685 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength CAPSULE;ORAL - 325MG;30MG Sponsor SOLVAY Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
PROVAL #3 (ACETAMINOPHEN; CODEINE PHOSPHATE) | Drug Monograph | MedicHelpline